# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001125345-24-000076
Filing Date
2024-04-08
Accepted
2024-04-08 16:31:25
Documents
5
Period of Report
2024-05-21

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | def_14ax2024.htm | DEF 14A | 969171
2 | SIGNATURE | imagea.jpg | GRAPHIC | 7365
3 | PVP CHART | chart-365ceeebfdf84d18954a.jpg | GRAPHIC | 127544
4 | PROXY CARD PAGE 1 | mgnx_pcxfinalxpagex1a.jpg | GRAPHIC | 1316501
5 | PROXY CARD PAGE 2 | mgnx_pcxfinalxpagex2a.jpg | GRAPHIC | 540086
| Complete submission text file | 0001125345-24-000076.txt |  | 3711175

Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36112 | Film No.: 24829991
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)